Angiodynamics (ANGO) Non-Current Debt (2011 - 2023)

Angiodynamics' Non-Current Debt history runs 13 years deep, the most recent figure standing at $49.8 million for Q2 2023.

• Quarterly Non-Current Debt rose 99.27% year-over-year to $49.8 million in Q2 2023, while the trailing twelve-month figure through May 2023 was $49.8 million (up 99.27% YoY) and the FY2023 annual result came in at $49.8 million, up 99.27% from the prior year.
• Non-Current Debt was $49.8 million for Q2 2023 at Angiodynamics, roughly flat from $49.8 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $133.1 million in Q1 2019 and bottomed at $14.3 million in Q1 2020.
• A 5-year average of $46.3 million and a median of $40.0 million in 2020 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2020 — Non-Current Debt sank 89.22% — and 2021, when it soared 109.19%.
• Angiodynamics' Non-Current Debt stood at $124.4 million in 2019, then sank by 67.85% to $40.0 million in 2020, then slumped by 37.5% to $25.0 million in 2021, then surged by 99.18% to $49.8 million in 2022, then increased by 0.04% to $49.8 million in 2023.
• Business Quant data shows ANGO's Non-Current Debt at $49.8 million in Q2 2023, $49.8 million in Q1 2023, and $49.8 million in Q4 2022.